Motivation: Heart failure affects more than 20 million people in the world. Heart transplantation is the most effective therapy, but the number of eligible patients far outweighs the number of available donor hearts. The left mechanical ventricular assist device (LVAD) has been developed as a successful substitution therapy that aids the failing ventricle while a patient is waiting for the donor heart. We obtained genomics data from paired human heart samples harvested at the time of LVAD implant and explant. The heart failure patients in our study were supported by the LVAD for various periods of time. The goal of this study is to model the relationship between the time of LVAD support and gene expression changes. Results: To serve the purpose, we propose a novel penalized partial least squares (PPLS) method to build a regression model. Compared with partial least squares and Breiman's random forest method, PPLS gives the best prediction results for the LVAD data.
Bibliographical noteFunding Information:
a Minnesota Medical Foundation grant. J.H. was supported by an AHA grant, the Lillehei Heart Institute and the Minnesota Medical Foundation.
The authors are grateful to the reviewers for helpful comments. X.H. and W.P. were supported by an NIH grant and